Tarsus Pharmaceuticals, Inc.

Q2 2021 13F Holders

Symbol
TARS
CUSIP
87650L103
Type
Equity
Class
COM
Num filings
46
Total reported value, excl. options
$416 M
Manager Report Date Value ($000) Shares Option Type